Compare Thomson Reuters Corp (TRI) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Thomson Reuters Corp vs UnitedHealth Group Inc — how do they compare? Thomson Reuters Corp trades at $97 (market cap $42.12B), while UnitedHealth Group Inc trades at $394.2 (market cap $352.81B). The key difference: UnitedHealth Group Inc is far larger — about 8.4× Thomson Reuters Corp's market cap, and Thomson Reuters Corp pays the higher dividend (2.7%). Which is the better fit depends on your goals.
| TRI | UNH | |
|---|---|---|
Market Cap | $42.12B | $352.81B |
Sector | Industrials | Health |
52-Week High | $173.48 | $436.35 |
52-Week Low | $76.55 | $259.02 |
Enterprise Value | $44.73B | $394.67B |
Dividend Yield | 2.7% | 2.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Thomson Reuters (TRI) trades at $98.81, down 6.5% recently, amid a bearish technical signal. The stock shows strong fundamentals with Q2 2026 earnings beating estimates at $0.99 per share and revenue growth of 9% year-over-year. Recent news highlights AI expansion with the launch of its proprietary LLM 'Thomson' and a cybersecurity incident affecting its case management system. Valuation ratios include a P/E of 26.03 and net income margin of 21.22%, indicating robust profitability but premium pricing.
Outlook is mixed: analyst consensus is bullish with a $113 price target, but technical weakness and cybersecurity risks pose headwinds. Investment opportunity lies in TRI's recurring revenue model and AI-driven growth, while risks include execution challenges and market sentiment shifts. The stock's current dip may offer a entry point for long-term investors focused on sustainable tech adoption.
UnitedHealth Group (UNH) trades at $393.06, down 1.03% on the day, with a bullish technical signal from moving averages and strong analyst support. The company reported revenue of $447.57B in 2025, with net income of $12.06B, and has beaten EPS estimates in recent quarters. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns via dividends and buybacks.
The outlook for UNH is positive, driven by aging demographics, Medicare growth, and operational efficiencies, though risks include regulatory scrutiny and margin pressures. With 82.7% of analysts rating it a buy and a consensus price target of $475.47, the stock presents a compelling opportunity for long-term investors seeking exposure to healthcare stability and dividend growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Thomson Reuters Corp
Thomson Reuters is the result of the $17.6 billion megamerger of Canada's Thomson and the United Kingdom's Reuters Group in 2008 and the 2018 carve-out of its finance and risk business, Refinitiv, in which it holds a 45% stake. In 2019, the company agreed to exchange its 45% stake in Refinitiv for a 15% stake in LSE, which closed in early 2021. Since the divestiture, the company is more concentrated on selling its flagship legal data and software, Westlaw, and its tax accounting software, Onesource. Reuters sees roughly 80% of revenue and 70% of expenses attributed to the United States, while the remainder (largely through the global print and Reuters News segments) is distributed across Latin America, Europe, the Middle East, Africa, and Asia-Pacific.
Read more on TRI →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
